Comment by phil

View Single Comment

phil
April 22nd, 2014 at 6:52 am
Novartis announces billions of dollars in deals with GSK, Eli Lilly
02:11 AM ET · NVS
• Novartis (NVS) has agreed to exchange certain assets with GlaxoSmithKline (GSK) and it is selling its animal-health division to Eli Lilly (LLY) for around $5.4B.
• Novartis will buy GSK’s oncology products for an initial $14.5B and up to $1.5B in development milestones. The Swiss company will also sell its vaccines business to its U.K. rival for $5.25B upfront and as much as $1.8B in milestones, as well as royalties. The latter deal doesn’t include Novartis’ flu business, which the company plans to sell separately.
• Novartis will also combine its over-the-counter operations with GSK Consumer Healthcare in a joint venture in which Novartis will own 36.5%.
• Eli Lilly will fold Novartis’ animal-health unit into its Elanco business, creating the second-largest company in the sector in terms of global revenue.
• Novartis PR, Eli Lilly PR
var isMC=true; var adSize=’320×50′; var ord = Math.floor(Math.random()*10e12); var seekingalpha_ad_src=’http://ad.doubleclick.net/N6001/adj/sek.mobile/app;sz=320×50,320×250;x=x;tile=1;d=mobile;t=app;mcid=true;mcid=1683853;s=NVS;s=GSK;s=LLY;’+dart_my_vocation_and_profiles()+’ord=’+ord+’;dev=ip?’; document.write(”);